Within BLMK, we are aware that health inequalities exist in the uptake of CGM technologies. 

Our BLMK Diabetes CGM, Insulin Pumps and Diabetes Technologies Working Group wanted to ensure our health inequalities do not worsen so we asked our local business intelligence team to produce a report which captures: 
• The number of Type 1 and Type 2 diabetic patients in BLMK
• Uptake of all CGM devices available via FP10 based on patients ethnicity, age, gender, deprivation and place 

The purpose of this report is to: 
• Monitor health inequalities to ensure they are not worsening 
• Explore the reasons why there is low uptake in certain patients 

We have been given approval to develop interventions that will be community focused to improve the results and equalise access.

Learning outcomes:

• In any clinical pathway or service we should acknowledge that health inequalities exist but are often hidden.
• Population health data should be used to highlight health inequalities. The data needs to robust and it is important to understand the limitations of the data when drawing conclusions.
• It is important to incorporate the patient voice to understand the barriers that are contributing to the health inequalities.
• Working collaboratively with commissioners, clinicians, patients and the voluntary sector is key to implementing a successful plan to improve the health inequalities.